Insider Transactions in Q1 2023 at Kala Pharmaceuticals, Inc. (KALA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Indirect |
66,131
+28.03%
|
-
|
|
Mar 10
2023
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Direct |
2,013
+28.04%
|
-
|
|
Mar 10
2023
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,977
+23.74%
|
-
|
|
Feb 15
2023
|
Mark S. Blumenkranz |
SELL
Other acquisition or disposition
|
Indirect |
70
-0.16%
|
-
|
|
Feb 15
2023
|
Mark S. Blumenkranz |
SELL
Other acquisition or disposition
|
Direct |
3
-0.1%
|
-
|
|
Jan 04
2023
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
198
-0.43%
|
$5,544
$28.54 P/Share
|
|
Jan 04
2023
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
41,700
+47.46%
|
-
|
|
Jan 04
2023
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
62
-0.42%
|
$1,736
$28.54 P/Share
|
|
Jan 04
2023
|
Todd Bazemore |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+46.21%
|
-
|
|
Jan 04
2023
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
73
-0.39%
|
$2,044
$28.53 P/Share
|
|
Jan 04
2023
|
Romulus K Brazzell |
BUY
Grant, award, or other acquisition
|
Direct |
12,800
+40.75%
|
-
|
|
Jan 04
2023
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
60
-0.5%
|
$1,680
$28.54 P/Share
|
|
Jan 04
2023
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,525
+44.37%
|
-
|
|
Jan 04
2023
|
Eric Trachtenberg |
SELL
Open market or private sale
|
Direct |
60
-0.52%
|
$1,680
$28.55 P/Share
|
|
Jan 04
2023
|
Eric Trachtenberg |
BUY
Grant, award, or other acquisition
|
Direct |
9,525
+45.19%
|
-
|
|
Jan 04
2023
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,525
+38.15%
|
-
|